|
mRNA_ID
|
Gene Name
|
drug_ID
|
drug_Name
|
Disease
|
RNA_exp_pattern
|
Evidence
|
Details
|
|
ENST00000682849
|
CT45A10
|
DB01262
|
Decitabine
|
epithelial ovarian cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000620704
|
CT45A9
|
DB01262
|
Decitabine
|
epithelial ovarian cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000611660
|
CT45A8
|
DB01262
|
Decitabine
|
epithelial ovarian cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000610598
|
CT45A7
|
DB01262
|
Decitabine
|
epithelial ovarian cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000620654
|
CT45A6
|
DB01262
|
Decitabine
|
epithelial ovarian cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000698999
|
CT45A5
|
DB01262
|
Decitabine
|
epithelial ovarian cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000598716
|
CT45A3
|
DB01262
|
Decitabine
|
epithelial ovarian cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000612907
|
CT45A2
|
DB01262
|
Decitabine
|
epithelial ovarian cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000594565
|
CT45A1
|
DB01262
|
Decitabine
|
epithelial ovarian cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000375123
|
FOXE1
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
squamous cell carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000380707
|
A-SMA
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
colorectal cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1 (E-cadherin)
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
colorectal cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000332029
|
SOCS1
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
colorectal cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000442011
|
TGFBI
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
ovarian cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000646209
|
THRB
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
thyroid tumor
|
up-regulated
|
validated
|
more...
|
|
ENST00000368636
|
BNIP3
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000302006
|
IRX1
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
gastric cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000403290
|
ARNTL
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
nasopharyngeal carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000231751
|
LTF
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
acute t lymphoblastic leukemia
|
up-regulated
|
validated
|
more...
|
|
ENST00000264832
|
ICAM1
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
sarcoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000328435
|
CTAG1B ( NY-ESO-1)
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
sarcoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000370278
|
MAGEA3
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
sarcoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000356661
|
MAGEA1
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
sarcoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000651593
|
MGMT
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
glioma
|
up-regulated
|
validated
|
more...
|
|
ENST00000324642
|
TERT
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
glioma
|
down-regulated
|
validated
|
more...
|
|
ENST00000382771
|
MASPIN
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
oral cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000359365
|
RASSF1A
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
endometrial cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000382592
|
LATS2
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
astrocytoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000543571
|
LATS1
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
astrocytoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000408954
|
DAPK
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
nasopharyngeal carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000286574
|
WIF1
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
cervical cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000382297
|
KANK1
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
nasopharyngeal carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000543571
|
LATS1
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
renal carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000264808
|
PRDM5
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
lung cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000373578
|
SRC
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
renal carcinoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000361726
|
Connexin32
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
renal carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000613740
|
EPHA5
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
breast cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000408954
|
DAPK1
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
kidney cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000408954
|
DAPK1
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
bladder cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000551964
|
APAF1
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
kidney cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000551964
|
APAF1
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
bladder cancer
|
up-regulated
|
validated
|
more...
|